The NRG Oncology Podcast podcast artwork
Health & Fitness

The NRG Oncology Podcast

by NRG Oncology
Share this ranking Claiming needs an RSS feed. Contact us.

Chart positions today · New Zealand

Not on the New Zealand charts we track today.

If you like The NRG Oncology Podcast, try…

Latest episodes

  • NRG-BR002 Published in JCO

    October 7, 2026 · 14 min

    For Breast Cancer Awareness Month, we discuss the results of the NRG-BR002 in newly oligometastatic breast cancer published in the Journal of Clinical Oncology today.

  • NRG-HN009 p16-Negative Results at ASTRO 2026

    September 29, 2026 · 14 min

    We discuss the reported results of the NRG-HN009 p16-negative cohort presented at the ASTRO Annual Meeting Late-Breaking Abstract Session.

  • NRG-CC009 and the MAVERICK Study at ASTRO 2026

    September 28, 2026 · 22 min

    We discuss both the NRG-CC009 study results presented during the 2026 ASTRO Annual Meeting Plenary Session and the MAVERICK study results presented during the Clinical Trials Session.

  • NRG-GI003 Results in the ASTRO 2026 Plenary

    September 28, 2026 · 14 min

    We discuss the NRG-GI003 results presented during the 2026 ASTRO Annual Meeting Plenary Session.

  • The SPPORT Study Analysis Results at ASTRO 2026

    September 27, 2026 · 12 min

    We interview Dr. Shang "George" Zhao on the NRG-RTOG 0534 "SPPORT" study results he presented at the 2026 ASTRO Annual Meeting Clinical Trials Session.

Show 7 more episodesShow fewer episodes
  • The NRG-GY036 Trial for Ovarian Cancer Month

    September 4, 2026 · 23 min

    For the 2026 Ovarian Cancer Month & Gynecologic Cancer Month, we discuss the currently enrolling NRG-GY036 clinical trial comparing 1 vs. 2 years of maintenance olaparib (with or without bevacizumab) for patients with advanced ovarian…

  • NRG-HN016: The "CONCISE" Study for Locoregionally Advanced Head and Neck Cancer Patients that are Unable to Take Cisplatin

    August 13, 2026 · 17 min

    Our co-hosts interview the PI of the active NRG-HN016 (CONCISE) trial, Dr. Loren Mell. The CONCISE study is a randomized phase III trial comparing radiation therapy (RT) plus carboplatin/paclitaxel vs. RT plus cetuximab for patients with…

  • NRG-GU015, the "ARCHER" Study for Muscle Invasive Bladder Cancer

    July 30, 2026 · 28 min

    Our co-hosts welcome Dr. Scott Delacroix and Dr. Himanshu Nagar to discuss bladder cancer, bladder preservation, and the newly activated NRG-GU015 (ARCHER) clinical trial. In this episode, the experts explore who may benefit from…

  • NRG2026 and Glioblastoma Awareness Day Special

    July 15, 2026 · 39 min

    For Glioblastoma Awareness Day we discuss the NRG-CC017 study of TMPRT + Temozolomide for glioblastoma with PI, Dr. Huang. We also discuss the challenges faced by larger institutions with Dr. Abraham.

  • Uterine Cancer Awareness Month 2026

    June 23, 2026 · 50 min

    This special Uterine Cancer Month episode includes three different perspectives in Uterine Cancer research. First we interview uterine and ovarian cancer survivor, NRG PAC Member, and Uterine Corpus Subcommittee Patient Advocate, Anna…

  • Prostate Cancer Analysis and Translational Science from ASCO 2026

    May 30, 2026 · 30 min

    In this episode, we discuss the results of the combined analysis of the prostate cancer studies RTOG 9202, 9413, 9902, and 0521 as well as learn more about translational science at NRG.

  • NRG-GY018 Mature Results from ASCO 2026

    May 29, 2026 · 18 min

    Our Podcast Co-Hosts interview NRG-GY018 study PI, Dr. Ramez Eskander on the reported mature results of the study in advanced or recurrent endometrial cancer at ASCO 2026.

Full episode archive on Apple Podcasts →

About the show

The NRG Oncology Podcast, developed by NRG Oncology, is hosted by Drs. Stephen Chun and Lauren Henke. Stephen and Lauren delve into a variety of topics impacting the oncology community via interviews with various stakeholders throughout the NRG Oncology organization.